Skip to Content

Felbamate Pregnancy and Breastfeeding Warnings

Felbamate is also known as: Felbatol

Felbamate Pregnancy Warnings

To provide information regarding the effects of in utero exposure to felbamate, physicians are advised to recommend that pregnant patients taking felbamate enroll in the North American Antiepileptic Drug (NAAED) Pregnancy Registry. This can be done by calling the toll free number 1-888-233-2334, and must be done by patients themselves. Information on the registry can also be found at the website

Felbamate has been assigned to pregnancy category C. Animal studies have revealed evidence of an increase in death rate and a decrease in body weight. There are no controlled data in human pregnancy. Felbamate should only be given in pregnancy when benefit outweighs risk.

See references

Felbamate Breastfeeding Warnings

Felbamate has been detected in human milk. The consequences for nursing infants are unknown.

See references

References for pregnancy information

  1. "Product Information. Felbatol (felbamate)." Wallace Laboratories, Cranbury, NJ.
  2. Adusumalli VE, Yang JT, Wong KK, Kucharczyk N, Sofia RD "Felbamate pharmacokinetics in the rat, rabbit, and dog." Drug Metab Dispos 19 (1991): 1116-25
  3. Wagner ML "Felbamate: a new antiepileptic drug." Am J Hosp Pharm 51 (1994): 1657-66

References for breastfeeding information

  1. "Product Information. Felbatol (felbamate)." Wallace Laboratories, Cranbury, NJ.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.